3 days popular7 days popular1 month popular3 months popular

SMi’s 3rd Annual Biobanking Event Creates A Buzz In The World Of Biobanking, 24-25 June 2013, London

SMi’s much anticipated 3rd Biobanking on 24th-25th May and is already proving to be very popular with esteemed industry professionals.

“Use of human biosamples is critical in enabling the discovery and validation of new targets and biomarkers”  , Director, Novartis – SPEAKER AT BIOBANKING 2013

“Biobanking has propelled research and researchers in a new era where innovation, reciprocity and universalism meet”…. – Ma’n H. Zawati,  Academic Associate, Centre  of Genomics  and Policy, McGill  University  – SPEAKER AT BIOBANKING 2013

In a first-of-its kind national survey published earlier this year by Genome Medicine, nearly 70% of the 456 US biobankers questioned, are worried that specimen samples are being underused. Nature Medicine Journel

With this in mind it is now more important than ever to build sustainable biobanks having improved access and longer bio-specimen lifecycles. In addition to the concerns of retention, biobanks are under constant pressure to meet quality standards and international regulations.

The ultimate success of biobanking will depend on overcoming both major technical and ethical challenges. This event aims to inform and guide delegates to overcome these challenges and enable them to understand and share best practice.


  • Julie Corfield, Director, Areteva 
  • Janine Swifka, Scientist, Bayer
  • Shaun Griffin, Director of Communications, HRA & HTA
  • Kristof Van Quathem, Data Protection Advisor, Covington & Burling LLP
  • Kirstin Goldring, , UCL Biobank

For further information on the conference contact John Collins on email [email protected] or call +44 (0)20 7827 6734



SMi Group Ltd